Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Misses Q4 EPS by 21c

March 1, 2021 4:17 PM EST

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q4 EPS of ($0.95), $0.21 worse than the analyst estimate of ($0.74).

Atara had a very strong year in 2020, delivering on key milestones across the Companys three strategic priorities, said Pascal Touchon, President and Chief Executive Officer of Atara. We anticipate... More